Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Physiol Pharmacol ; 71(1)2020 Feb.
Article in English | MEDLINE | ID: mdl-32554847

ABSTRACT

Type 2 diabetes mellitus (T2DM) increases cardiovascular complications. Diabetic vascular dysfunction is associated with the reduced activity of the different smooth muscle potassium (K+) channels. Thus, the objective of our study was to investigate the role of the adenosine triphosphate (ATP)-sensitive K+ (KATP) channels in the relaxant effect of potassium channel opener, pinacidil on the human saphenous vein (HSV) obtained from the patients with and without T2DM. The rings of HSV without the endothelium, obtained from the patients who had undergone coronary bypass surgery, were mounted in an organ bath system and isometric tension was recorded. The relaxation of HSV, precontracted with phenylephrine, was produced by pinacidil. The expression of KATP subunits (Kir6.1, Kir6.2 and SUR2B) was detected by immunohistochemistry and Western blot. Pinacidil produces comparable effects on HSV in patients with and without T2DM. The suppression of pinacidil effect and its maximal relaxation by glibenclamide, selective blocker of KATP channels, was more pronounced on HSV in patients without T2DM. All three types of KATP subunits are expressed on the smooth muscle cells of HSV. While there are no differences in the expression of Kir6.1 and Kir6.2, the expression of SUR2B is lower in HSV in patients with T2DM. Pinacidil produced comparable KATP-dependent and -independent relaxation of the HSV in patients with/without T2DM. According to the effect of glibenclamide and the applied molecular analysis, presented findings demonstrated that diabetes mellitus was associated with the reduced expression of SUR2B subunit in the vascular smooth muscle of HSV.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , KATP Channels/metabolism , Pinacidil/pharmacology , Saphenous Vein/drug effects , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Aged , Diabetes Mellitus, Type 2/physiopathology , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Organ Culture Techniques , Saphenous Vein/physiology , Vasodilation/physiology
2.
Exp Clin Endocrinol Diabetes ; 123(5): 303-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25988879

ABSTRACT

Nitric oxide synthases (NOSs) and Na(+)/K(+)-ATPase are enzymes essential for regular functioning of the heart. Since both enzymes are under insulin and androgen regulation and since insulin action and androgen level were disturbed in polycystic ovary syndrome (PCOS), we hypothesized that cardiac nitric oxide (NO) production and sodium/potassium transport would be deteriorated in PCOS. To test our hypothesis we introduced animal model of PCOS based on dihydrotestosterone (DHT) treatment of female Wistar rats and analyzed protein expression, phosphorylation or subcellular localization of endothelial NOS (eNOS), inducible NOS (iNOS) and alpha subunits of Na(+)/K(+)-ATPase in the heart. Obtained results indicate that DHT treatment significantly decreased cardiac eNOS protein level and activating phosphorylation at serine 1,177, while inhibitory phosphorylation at threonine 495 was increased. In contrast to expression of eNOS, iNOS protein level in the heart of DHT-treated rats was significantly elevated. Furthermore, cardiac protein level of alpha 1 subunit of the ATPase, as well as its plasma membrane content, were decreased in rats with PCOS. In line with this, alpha 2 subunit protein level in fraction of plasma membranes was also significantly below control level. In conclusion, DHT treatment impaired effectiveness of NOSs and Na(+)/K(+)-ATPase in the female rat heart. Regarding the importance of NO production and sodium/potassium transport in the cardiac contraction and blood flow regulation, it implicates strong consequences of PCOS for heart functioning.


Subject(s)
Disease Models, Animal , Myocardium/enzymology , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type II/metabolism , Polycystic Ovary Syndrome/enzymology , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Cell Membrane/enzymology , Cell Membrane/metabolism , Dihydrotestosterone , Down-Regulation , Female , Myocardium/metabolism , Phosphorylation , Polycystic Ovary Syndrome/metabolism , Protein Processing, Post-Translational , Protein Transport , Random Allocation , Rats, Wistar , Serine/metabolism , Threonine/metabolism , Up-Regulation
3.
Horm Metab Res ; 47(7): 521-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25369074

ABSTRACT

The renin-angiotensin system has been implicated in the development of metabolic syndrome and appears to be a key in the local tissue control of normal cardiac functions. Physiological concentrations of estrogens have been shown to be cardioprotective, especially against the damaging effects of fructose-rich diet. The aim of the study was to investigate the expression of the renin-angiotensin system molecules with potentially deleterious effect on the heart (angiotensin-converting enzyme and angiotensin II type 1 receptor) and those with potentially protective effects, (angiotensin-converting enzyme 2 and angiotensin II type 2 receptor), in ovariectomized fructose fed female rats with 17ß-estradiol replacement. Real-time PCR and Western blot analysis were used for quantification of gene and protein expression in the heart. Fructose diet increased the expression of angiotensin-converting enzyme and angiotensin II type 1 receptor and decreased the expression of angiotensin-converting enzyme 2 and angiotensin II type 2 receptor. On the other hand, estradiol replacement seems to undo fructose diet effects on cardiac renin-angiotensin system. Downregulation of angiotensin-converting enzyme and angiotensin II type 1 receptor, and reversion of expression of both potentially protective molecules, angiotensin-converting enzyme 2 and angiotensin II type 2 receptor, to the control level in cardiac tissue took place. Obtained results suggest that estradiol may reverse the harmful effect of fructose-rich diet on the expression of renin-angiotensin system molecules. These findings may also be important in further research of phenotypes like insulin resistance, metabolic syndrome, and following cardiovascular pathology in females.


Subject(s)
Estradiol/pharmacology , Fructose/administration & dosage , Heart/drug effects , Myocardium/metabolism , Renin-Angiotensin System/drug effects , Animals , Diet , Female , Ovariectomy , Peptidyl-Dipeptidase A/metabolism , Rats , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 2/metabolism , Renin-Angiotensin System/physiology
4.
Horm Metab Res ; 46(2): 109-15, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24043574

ABSTRACT

Remarkable parallels are observed between glucose transporters (GLUT) and subunits of Na+/K+-ATPase, which deal with insulin regulation, tissue specificity, intracellular distribution and function of these proteins. To test our hypothesis that similarities also exist in alteration of cardiac GLUTs and alpha subunit isoforms of the pump in insulin resistance, animal model of fructose rich diet was exploited. The role of estradiol in regulation of GLUTs and Na+/K+-ATPase in insulin resistance context was studied as well. Cardiac protein expression, as well as insulin-regulated cellular localization of GLUT4, GLUT1, and α1 and α2 subunits of the pump were analyzed by Western blot. Fructose rich diet increased plasma insulin level and HOMA index, while estradiol treatment reversed both parameters to the control level. We did not observe obvious similarities in the pattern of alterations of GLUT1/α1 subunit of the pump, as well as GLUT4/α2 subunit, related to diet or hormone treatment. Considering alterations in expression and cellular localization of GLUTs and the pump subunits, fructose rich diet jeopardized cardiac glucose transport in some extent, but in contrast, stimulated Na+/K+-ATPase function. Estradiol treatment opposed the fructose diet biochemical action and the effect on cardiac GLUTs, but was inefficient concerning the changes of cardiac Na+/K+-ATPase subunits. Changes of the cardiac molecules can be mediated by alterations in the level of insulin and nonesterified fatty acids, induced by the diet and hormone treatment.


Subject(s)
Estradiol/physiology , Fructose/administration & dosage , Glucose Transport Proteins, Facilitative/analysis , Myocardium/chemistry , Sodium-Potassium-Exchanging ATPase/analysis , Animals , Diet , Estradiol/administration & dosage , Female , Glucose Transporter Type 1/analysis , Glucose Transporter Type 4/analysis , Insulin/blood , Insulin Resistance , Ovariectomy , Rats , Rats, Wistar
5.
Horm Metab Res ; 43(8): 524-30, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21773965

ABSTRACT

The estrogen binding to specific extranuclear receptors (ER) activates several intracellular pathways that are activated by insulin as well. Moreover, insulin and estradiol (E2) influence cardiac energy substrates, blood glucose and free fatty acids (FFAs), and both hormones exert cardio-beneficial effects. In view of these facts, we suggest that cross-talk between their signaling pathways might have an important role in regulation of cardiac energy substrate transport. Ovariectomized rats were treated with insulin, estradiol (E2), or their combination 20, 30, or 40 min before analysis of blood glucose and FFA level, as well as cardiac plasma membranes (PM) and low density microsomes (LDM) content of glucose (GLUT4 and GLUT1) and FFA (CD36) transporters. Insulin, given alone, or in combination with E2, decreased plasma glucose level at all time points, but did not influence FFA level, while E2 treatment itself did not change glucose and FFA concentration. Insulin increased PM GLUT4 and GLUT1 content 30 and 40 min after treatment and the increases were partially accompanied by decrease in transporter LDM content. E2 increased PM content and decreased LDM content only of GLUT4 at 30 min. Insulin generally, and E2 at 20 min increased CD36 content in PM fraction. Both hormones decreased CD36 LDM content 20 min after administration. Effect of combined treatment mostly did not differ from single hormone treatment, but occasionally, particularly in distribution of GLUT4, combined treatment emphasized single hormone effect, suggesting that insulin and E2 act synergistically in regulation of energy substrate transporters in cardiac tissue.


Subject(s)
Blood Glucose/metabolism , Estradiol/pharmacology , Fatty Acids, Nonesterified/blood , Insulin/pharmacology , Membrane Transport Proteins/metabolism , Myocardium/metabolism , Animals , CD36 Antigens/metabolism , Cell Membrane/drug effects , Cell Membrane/metabolism , Estradiol/administration & dosage , Estradiol/blood , Female , Glucose Transporter Type 1/metabolism , Glucose Transporter Type 4/metabolism , Insulin/administration & dosage , Insulin/blood , Microsomes/drug effects , Microsomes/metabolism , Rats , Rats, Wistar
6.
Pharmazie ; 63(2): 151-5, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18380403

ABSTRACT

Nitric oxide (NO) has been shown to mediate nonadrenergic-noncholinergic relaxation in gastrointestinal (GI) smooth muscle cells. As GI smooth muscles relaxations are partly dependent on NO, we decided to investigate the effect of sodium nitroprusside (SNP) on the longitudinal muscle contraction of the isolated guinea pig ileum. Increasing concentrations of SNP (10(-10)M, 10(-9)M, 10(-8)M, 10(-7)M, 10(-6)M and 10(-5)M) reduced ileum contractions stimulated by electrical stimulation (ES) (8-76%; p < 0.05) and by acetylcholine (Ach) (23-62%; p < 0.05) significantly and in a concentration-dependent manner. Furthermore, treatment with an inhibitor of the soluble guanylate cyclase, methylene blue (10 mM), antagonized significantly the relaxing effect of SNP (0-39%; p < 0.05, p < 0.01, p < 0.001 for ES- and 4-27%; p < 0.05 for Ach-induced contractions). The results show that treatment with 1 microM manganese-containing superoxide dismutase (MnSOD) and 10 microM L-arginine (L-arg) caused a significant decrease in SNP induced relaxations (6-55%; p < 0.05, p < 0.001 and 2-46%; p < 0.05, p < 0.01 for ES- and 15-28%; p < 0.05, p < 0.01, p < 0.001 and 12-32%; p < 0.05, p < 0.01 for Ach-induced contractions, respectively). In conclusion, our data suggest that SNP, which releases NO, is able to depress longitudinal muscle contraction of the isolated guinea pig ileum, suggesting that exogenous application of NO inhibits intestinal contractions of smooth muscle cells and that cGMP mediates the response to NO. In addition, MnSOD and L-arg decreased the relaxing effect of SNP on the isolated ileum of the guinea pig.


Subject(s)
Gastrointestinal Tract/drug effects , Muscle, Smooth/drug effects , Nitroprusside/pharmacology , Vasodilator Agents/pharmacology , Animals , Arginine/pharmacology , Female , Free Radical Scavengers/pharmacology , Guanylate Cyclase/metabolism , Guinea Pigs , Ileum/drug effects , In Vitro Techniques , Male , Muscle Relaxation/drug effects , Solutions , Superoxide Dismutase/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...